CTCAE RápidoAdverse event grades · CTCAE v6.0
Código Onco

Retinoic acid syndrome

Neoplasms benign, malignant and unspecified (incl cysts and polyps)
  1. G1Fluid retention; <3 kg of weight gain; intervention with fluid restriction and/or diuretics indicated
  2. G2Moderate signs or symptoms; steroids indicated
  3. G3Severe symptoms; hospitalization indicated
  4. G4Life-threatening consequences; ventilatory support indicated
  5. G5Death
Definition and note

DefinitionA disorder characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis and/or renal failure originally described in patients treated with all-trans retinoic acid.

MedDRA code (LLT): 10038921 · CTCAE v6.0 (NCI), original English text.

Other events in Neoplasms benign, malignant and unspecified (incl cysts and polyps)

Differentiation syndromeKeratoacanthomaLeukemia secondary to oncology chemotherapyMyelodysplastic syndromeNeoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specifySkin papillomaTreatment related secondary malignancyTumor hemorrhageTumor pain

Search another event

From the same authorCódigo OncoCódigo Onco (in Portuguese): Brazilian public health system (SUS) codes for systemic cancer treatment.